2021 EHRA practical guide on NOACs in AF: What’s new, what’s hot
30 Aug 2021
byDr. Wee Siong Teo, Mount Elizabeth Medical Centre, Singapore
Non-vitamin K antagonist oral anticoagulants (NOACs) are the preferred choice of anticoagulants for stroke prevention in patients with atrial fibrillation (AF) in international guidelines. A leading expert in the field, Senior Consultant Cardiologist Dr Teo Wee Siong from Mount Elizabeth Medical Centre, Singapore, shared his insights on the 2021 EHRA* practical guide on NOACS in AF, how to personalize NOACs therapy, including apixaban (Eliquis, Pfizer), and manage difficult treatment scenarios. Dr Teo was past President of APHRS** and is currently President of HRAS***.